scholarly journals Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update

2012 ◽  
Vol 87 (6) ◽  
pp. 817-830 ◽  
Author(s):  
Thamy Yamashita ◽  
Luciana Patricia Fernandes Abbade ◽  
Mariangela Esther Alencar Marques ◽  
Silvio Alencar Marques
Keyword(s):  
Diagnostic Criteria ◽  
Mycosis Fungoides ◽  
Staging System ◽  
Great Variability ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Clinical Expression ◽  
Early Stages

This paper reviews the diagnostic and classificatory concepts of mycosis fungoides and Sézary syndrome in light of the latest normative publications. It describes the great variability of the clinical expression of mycosis fungoides in its early stages as well as the histopathological and immunohistochemical aspects that help with diagnosis. The diagnostic criteria required for characterizing Sézary syndrome and the staging system used for both mycosis fungoides and Sézary syndrome are described.

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood ◽  
2007 ◽  
Vol 110 (6) ◽  
pp. 1713-1722 ◽  
Author(s):  
Elise Olsen ◽  
Eric Vonderheid ◽  
Nicola Pimpinelli ◽  
Rein Willemze ◽  
Youn Kim ◽  
...  
Keyword(s):  
Mycosis Fungoides ◽  
Cell Biology ◽  
Task Force ◽  
Prognostic Significance ◽  
Staging System ◽  
Cutaneous Lymphoma ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
European Organization ◽  
Cutaneous Lymphomas

Abstract The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.

Does the New Staging System Proposed for Mycosis Fungoides and Sézary Syndrome Provide Reliable Agreement for T1 and T2 Disease?

Dermatology ◽  
2014 ◽  
Vol 230 (1) ◽  
pp. 40-45 ◽  
Author(s):  
Ricardo Fernández-de-Misa ◽  
Buenaventura Hernández Machín ◽  
Armando Aguirre-Jaime ◽  
Lina Inmaculada Pérez-Méndez ◽  
Yeray Peñate ◽  
...  
Keyword(s):  
Mycosis Fungoides ◽  
Staging System ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
T1 And T2

Mycosis fungoides? Sezary syndrome

1970 ◽  
Vol 101 (2) ◽  
pp. 244-246 ◽  
Author(s):  
H. H. Roenigk
Keyword(s):  
Mycosis Fungoides ◽  
Sézary Syndrome ◽  
Sezary Syndrome
Sign in / Sign up

Export Citation Format

Share Document